Live Breaking News & Updates on Orcosa Inc

Stay updated with breaking news from Orcosa inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

IV tranexamic acid may not impact outcomes after tibial tubercle osteotomy

SAN FRANCISCO — Use of IV tranexamic acid during tibial tubercle osteotomy did not significantly impact blood loss or hemarthrosis, opioid consumption, postoperative pain or functional outcomes, according to results presented here. Michael J. Alaia, MD, and colleagues categorized patients undergoing tibial tubercle osteotomy into groups to receive either 1 g of IV tranexamic acid ....

United States , San Francisco , Michaelj Alaia , Arthroscopy Association Of North America Annual Meeting , Arthroscopy Association Of North America , Arthrex Inc , Orcosa Inc , American Academy Of Orthopaedic Surgeons , Arthroscopy Association , North America Annual , American Academy , Orthopaedic Surgeons , North America , Joint Preservation ,